Target Name: MIR412
NCBI ID: G574433
Other Name(s): mir-412 | microRNA 412 | hsa-mir-412 | hsa-miR-412-5p | hsa-miR-412-3p | MicroRNA 412 | MIRN412

MIR412: A Potential Drug Target and Biomarker

MIR412, also known as ITGB3, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and a potential drug candidate for development.

MIR412 is a small non-coding RNA molecule that is expressed in various tissues and cells in the body. It is a key regulator of the stem-cell proliferation and differentiation, and has been shown to play a role in the development and progression of various diseases.

One of the most promising aspects of MIR412 is its potential as a drug target. Its unique structure and function make it an attractive target for small molecule inhibitors, which can be used to treat a variety of diseases. MIR412 has been shown to interact with various proteins, including the transcription factor ASXL1, which is known to play a role in the development of cancer.

In addition to its potential as a drug target, MIR412 has also been shown to be a potential biomarker for various diseases. Its expression has been shown to be affected by a variety of factors, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it a promising biomarker for these diseases, and could be used for the development of early detection methods and personalized treatments.

Another promising aspect of MIR412 is its role in the regulation of stem cell proliferation and differentiation. MIR412 has been shown to play a key role in the regulation of stem cell proliferation, and has been shown to interact with the transcription factor DNMT1. This suggests that MIR412 may be involved in the regulation of stem cell growth and differentiation, and that it may be a potential target for drugs that are used to treat cancer and other stem cell-related diseases.

In conclusion, MIR412 is a non-coding RNA molecule that has shown promise as a drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for small molecule inhibitors, and its potential as a biomarker for cancer and other diseases makes it a promising candidate for further research. Further studies are needed to fully understand the role of MIR412 in the regulation of stem cell proliferation and differentiation, and to determine its potential as a drug target and biomarker.

Protein Name: MicroRNA 412

More Common Targets

MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430